IRI Separation Technologies Inc.

IRI Separation Technologies Inc.

March 17, 2008 16:00 ET

IRI Separation Technologies Inc. Announces Marketing Update

VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 17, 2008) - IRI Separation Technologies Inc. (TSX VENTURE:IRI) is pleased to announce it will now proceed to market its first product in the retail and direct marketing channels through the agents which have been retained for that purpose. The marketing program for our registered trademarked product "MUNO" is in the final stages of completion.

It is anticipated that the product will be available during late April 2008. The first product will be a 60 capsule bottle under the brand name MUNO with the initial launch to be in the Province of British Columbia.

"This is a very exciting time for IRI as we move to the marketing phase with our new product. We expect that the market will be pleased with our new product introduction and they can look forward to seeing additional products in the coming months," said Rick Stiksma, President and CEO.

About IRI Separation Technologies Inc.

IRI Separation Technologies Inc. (TSX VENTURE:IRI) is a biotechnology company that specializes in the extraction, development and commercialization of polyclonal immunoglobulin antibodies for virus and bacteria related health issues. Intended for use as a nutraceutical for human consumption, the antibodies are derived from chicken eggs. The immunoglobulin antibodies are intended for both the general and specific antibody market.

On behalf of the Board of Directors, John Mason, Chairman.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this news release.

Contact Information